EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

American Shared Hospital Service (AMS) fair value: what the stock is really worth

We calculate from audited financials what American Shared Hospital Service is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · ISIN US0295951059

AS American Shared Hospital Service logo Thin data Sep 13, 2026

American Shared Hospital Service

AMS · US

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value $4.26 · Strongly undervalued (+200%)
!Quality 30/100
!Expensive Growth (revenue 5y +9.5 %/yr)
!Loss-making · -5.3% net margin (TTM)
!Low debt · negative free cash flow
!Mixed vs. peers (6/11)
!Narrow moat 10/100
!Evidence only low, so the estimate is less certain
Watch American Shared Hospital Service for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$3.69 $1.29 Fair Value $4.26 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

60‑month range $1.29 – $3.69 · fair‑value band $2.57 – $5.95 · the $1.42 price screens below the $4.26 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 13, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service.

Show more

American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Stock analysis

American Shared Hospital Service (AMS) currently trades at $1.42, while our model-based Fair Value estimate is $4.26, implying the stock looks roughly 66.7% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $8.34 per share, and 2 of the 4 models we run sit above the $1.42 price.

Bear case: the Dividend Discount group reads lowest at $0.9600, and 2 of the 4 models stay below the price. Evidence for this calculation is low.

Scenario range: $2.57 (bear) to $5.95 (bull), the price of $1.42 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

American Shared Hospital Service reported revenue of $28.1M in FY2025 versus $17.6M in FY2021, a compound +12.3%/yr. Reported net income was −$1.6M in FY2025.

Key figures

Market cap $9.4M · P/S ratio 0.33 · EPS (TTM) $−0.2200 · Dividend yield 7.3% · Net margin −5.5% · Return on equity −9.5% · Return on assets (EBIT) 0.2% · Operating margin −8.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).

What moves the price

The share trades about 54% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at 200%, AMS screens cheaper than that median.

Fair Value models

Bear $2.57 Fair Value $4.26 Bull $5.95
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Gordon GGM $0.7300 $1.01 $1.26 69
DDM Multi-Stage $0.7300 $0.9600 $1.17 67
EV/EBITDA $6.39 $8.34 $10.30 67
All 4 models by family
Dividend Discount
Gordon GGM $0.7300 $1.01 $1.26 69
DDM Multi-Stage $0.7300 $0.9600 $1.17 67
Multiples
EV/EBITDA $6.39 $8.34 $10.30 67
Asset-Based
NCAV (Graham) $1.81 $2.43 $3.63 54

Open the full fair value analysis →

Notify me when AMS reaches fair value

Put AMS on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 30/100

Of which business quality 31 · Market factors (momentum, volatility) 23

Profitability 11
Margins and returns on capital today
Quality Growth 16
Are margins and returns improving?
Cashflow 15
Earnings quality: real cash, not paper profit
Fin. Strength 36
Balance sheet, leverage, solvency risk
Investment 47
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 16
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 80
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 22/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−0.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.5%
Revenue growth 40 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.6%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−53.1% (2020) → −7.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch AMS, get fair value alerts →

Compare American Shared Hospital Service with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 256 stocks

Beats the industry median on 6/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 30 · Bottom 25%
Fair Value upside +200% · Top 25%
Profitability
Return on assets −2% · Bottom 25%
Net margin (TTM) −5% · Bottom 25%
Operating margin (TTM) −9% · Bottom 25%
Growth and dividend
Revenue growth 16% · Top 25%
Dividend yield (TTM) 7.3% · Top 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B 0.39× · Cheapest 25%
P/S (TTM) 0.33× · Cheapest 25%
EV/EBITDA 1.5× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 33
FUTURE (revenue growth)80 · sector 27
PAST (return on equity)0 · sector 31
HEALTH (low debt)100 · sector 90
DIVIDEND (yield)0 · sector 42

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $430.43 $506.40 +18%
Fresenius SE FRE €46.12 €32.15 −30%
Dr. Sulaiman Al Habib Medical Services Group 4013 228.00 SAR 112.37 SAR −51%
IHH Healthcare Berhad, an investment holding company, Q0F 2.45 SGD 1.51 SGD −38%
Tenet Healthcare Corporation THC $265.78 $294.55 +11%
DaVita Inc DVA $193.86 $180.71 −7%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,850 ₹2,955 −67%
Fresenius Medical Care AG FMS $22.97 $46.01 +100%
Aier Eye Hospital Group 300015 ¥7.95 ¥10.86 +37%
Encompass Health Corporation EHC $123.91 $93.95 −24%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

American Shared Hospital Service · Fair Value
$4.26 +67%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "American Shared Hospital Service Fair Value". https://www.fairvalue-calculator.com/stock/AMS

Frequently asked questions

Is American Shared Hospital Service (AMS) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of $4.26 versus a price of $1.42, about +200% upside (undervalued).
What is the fair value of AMS?
Our model-based fair value for American Shared Hospital Service is $4.26 (as of Sep 13, 2026), built from audited fundamentals. The current price: $1.42.
What is the quality score of AMS?
American Shared Hospital Service has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for American Shared Hospital Service (AMS)?
Our model-based price target is the fair value of $4.26 (as of Sep 13, 2026) from 4 valuation models. Cautious scenario $2.57, optimistic scenario $5.95. It is a calculation from audited fundamentals, not an analyst target.
What is the American Shared Hospital Service stock forecast for 2026?
Our models put fair value at $4.26, about +200% upside versus a price of $1.42 (undervalued). Cautious scenario $2.57, optimistic scenario $5.95. The calculation is refreshed regularly with new filings.
What is the revenue of American Shared Hospital Service (AMS)?
American Shared Hospital Service reported trailing-twelve-month revenue of about $29.1M (latest available figure, as of Sep 13, 2026).
Does American Shared Hospital Service pay a dividend?
American Shared Hospital Service currently shows a dividend yield of about 7.28% relative to its recent price (as of Sep 13, 2026).
What is the intrinsic value of American Shared Hospital Service (AMS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For American Shared Hospital Service it is $4.26 per share (as of Sep 13, 2026), against a price of $1.42. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is American Shared Hospital Service stock overvalued or undervalued in 2026?
As of Sep 13, 2026, AMS trades below its calculated fair value: price $1.42, fair value $4.26, a gap of about +200% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AMS?
No. The price is what the market pays today ($1.42); the fair value is what the company's own numbers justify ($4.26). For American Shared Hospital Service the two are $2.84 per share apart. That gap is exactly why we show both numbers side by side.
How much is American Shared Hospital Service worth?
The market values American Shared Hospital Service at about $9.4M (market capitalisation, as of Sep 13, 2026). Per share that is $1.42; our models calculate a fair value of $4.26 per share.
What do the bullish and bearish scenarios say about AMS?
Our models span a range for American Shared Hospital Service: cautious scenario $2.57, base $4.26, optimistic $5.95 per share (as of Sep 13, 2026, price $1.42). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of American Shared Hospital Service (AMS)?
Balance-sheet figures for American Shared Hospital Service (as of Sep 13, 2026): return on equity −9.5%. They feed the Quality Score of 30/100, which measures business quality independently of the share price.
How far is AMS from its 52-week high?
American Shared Hospital Service trades at $1.42, about 54% below its 52-week high of $3.11 and 14% above the low of $1.25 (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of $4.26 is for.
Which stocks are comparable to American Shared Hospital Service?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is American Shared Hospital Service stock attractive at the current price?
The data as of Sep 13, 2026: price $1.42, calculated fair value $4.26 (+200%), Quality Score 30/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AMS calculated?
We run American Shared Hospital Service through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $4.26, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 16.1 % above its aggregate fair value. American Shared Hospital Service currently trades 200 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of American Shared Hospital Service (AMS)?
The closing price on Sep 18, 2026 was $1.42. Our model-based fair value is $4.26, about +200% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with American Shared Hospital Service right now?
The large discount to fair value meets weak quality (30/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($2.57). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($2.57 to $5.95) leaves room in how you read the outcome.

Key figures of American Shared Hospital Service

How large is the market capitalisation of American Shared Hospital Service (AMS)?
The market capitalisation of American Shared Hospital Service is $9.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of American Shared Hospital Service (AMS)?
The price-to-sales ratio of American Shared Hospital Service is 0.33 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of American Shared Hospital Service (AMS)?
Earnings per share at American Shared Hospital Service are $−0.2200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of American Shared Hospital Service (AMS)?
The dividend yield of American Shared Hospital Service is 7.3%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of American Shared Hospital Service (AMS)?
The net margin of American Shared Hospital Service is −5.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of American Shared Hospital Service (AMS)?
The return on equity (ROE) of American Shared Hospital Service is −9.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of American Shared Hospital Service (AMS)?
On an EBIT basis the return on assets of American Shared Hospital Service is 0.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of American Shared Hospital Service (AMS)?
The operating margin of American Shared Hospital Service is −8.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at American Shared Hospital Service (AMS)?
Revenue at American Shared Hospital Service is growing +15.9% versus a year earlier (3y avg +12.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at American Shared Hospital Service (AMS)?
Earnings per share at American Shared Hospital Service are growing −38.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does American Shared Hospital Service (AMS) generate?
The free cash flow of American Shared Hospital Service is −$4.5M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does American Shared Hospital Service (AMS) carry?
The net debt of American Shared Hospital Service is $19.1M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch American Shared Hospital Service in the live analysis

One click puts American Shared Hospital Service on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.